期刊文献+

1,25二羟基维生素D3缓解急性实验性自身免疫性脑脊髓炎的机制 被引量:2

1, 25-dihydroxyvitamin D3 promotes the apoptosis of inflammatory cells in acute experimental autoimmune encephalomyelitis:experiment with rats
原文传递
导出
摘要 目的探讨1,25二羟基维生素D3迅速减轻实验性自身免疫性脑脊髓炎(EAE)的机制。方法建立Lewis大鼠急性EAE模型;预防组及治疗组分别于致敏日及症状出现日投给1,25二羟基维生素D3。致敏后第13天处死,观察中枢神经系统病理改变,TUNEL法检测凋亡细胞,免疫组化法检测iNOS、FasL及TGF-B1的表达,并测定外周血单个核细胞(MNC)培养上清液中亚硝酸盐的含量。结果1,25二羟基维生素D,干预的预防组及治疗组与其相应对照组比较,I临床评分及病理评分均降低(均P〈0.01),凋亡细胞数增加(均P〈0.01),半定量iNOS阳性细胞数减少,但TGF-β1、FasL阳性细胞数无明显变化。1,25二羟基维生素D3干预后,EAE大鼠外周血单个核细胞培养上清中亚硝酸盐含量有增加趋势,但与对照组的差异无统计学意义。结论1,25二羟基维生素D3通过增加炎性细胞凋亡迅速缓解EAE症状,其原因可能与改变中枢神经系统的内环境有关。 Objective To investigate the mechanism of rapid amelioration of the pathological changes in experimental allergic encephalomyelitis (EAE) by 1,25-dihydroxyvitamin D3 [ 1,25-( OH)2D3 ]. Methods Forty Lewis rats were immunized with myelin basic protein in complete Freud~ adjuvant so as to establish ESE animal models and then randomly divided into 4 equal groups : prevention group, fed with 1, 25-(OH)2D3 since day 0 for 10 days, prevention-control group fed with peanut oil for 10 days, treatment group fed with 1, 25-(OH) 2D3 since the appearance of EAE symptoms (generally since day 10 or 11 ), and treatment-control group fed with peanut oil since the appearance of EAE symptoms. The clinical symptoms were scored since immunization till day 12 when the clinical symptoms reached the maximum level. The rats were sacrificed 13 days after sensitization with their brains and spinal cords taken out to undergo pathological examination, in situ TUNEL staining for detecting apeptotic cells, and semiquantitative immunohistnchemical analysis to detect the inducible NO synthase (iNOS), FasL, and tumor growth factor (TGF)-β1, that might involve in the signal pathway of apoptosis. Peripheral blood samples were collected to isolate mononuclear cells (MNCs). The content of nitrite in the supernatant of MNC culture was evaluated. Results The scores of clinical symptoms and the pathological changes of both the prevention and treatment groups decreased conspicuously and were significantly lower than their respective control groups ( both P 〈 0.01 ). In contrast, the apoptosis indexes of the 2 1, 25-(OH) 2D3 administration groups were significantly higher than those of the control groups (all P 〈0.01 ). The TUNEL positive cell rates in the brain and spinal cord of the treatment and prevention groups were all significantly higher than those of their corresponding control groups (P 〈 0. 05, P 〈 0.01 ). The numbers of iNOS positive cells in the treatment and prevention groups were both lower than those of their corresponding control groups, which was in accord with the improvement of clinical signs and tissue lesions. The levels of nitrite in the supernatant of MNC culture of the treatment and prevention groups were higher than those of their corresponding control groups, but not significantly. Conclusion Administration of 1, 25-( OH ) 2D3 rapidly ameliorates EAE symptoms by promoting the apoptosis of inflammatory cells. The elimination of infiltrating immune cells which reverses the pathological changes in Central nervous system is associated with a favorable microenvironment provided by 1,25-(OH) 2D3, such as decreasing of iNOS.
出处 《中华医学杂志》 CAS CSCD 北大核心 2008年第33期2350-2354,共5页 National Medical Journal of China
关键词 脑脊髓炎 自身免疫性 实验性 骨化三醇 凋亡 Encephalomyelitis, autoimmune, experimental Calcitriol Apoptosis
  • 相关文献

参考文献16

  • 1Brown SJ. The role of vitamin D in multiple sclerosis. Ann Pharmacother, 2006, 40: 1158-1161.
  • 2Smolders J, Damoiseaux J, Manheere P, et al. Vitamin D as an immune modulator in multiple sclerosis, a review. J Neuroimmunol, 2008, 194: 7-17.
  • 3Garcion E, Sindji L, Nataf S, et al. Treatment of experimental autoimmune encephalomyelitis in rat by 1,25-dihydroxyvitamin D3 leads to early effects within the central nervous system. Acta Neuropathol,2003, 105:438-448.
  • 4张凤,富羽弘,王维治,杨宝峰.实验性自身免疫性脑脊髓炎大鼠中1,25二羟基维生素D_3的免疫调节作用[J].中华神经科杂志,2005,38(10):612-616. 被引量:5
  • 5Spach KM, Pedersen LB, Nashold FE, et al. Gene expression analysis suggests that 1, 25-dihydroxyvitamin D3 reverses experimental autoimmune encephalomyelitis by stimulating inflammatory cell apoptosis. Physiol Genomics, 2004 , 18 : 141- 151.
  • 6焦卓敏,富羽弘,王维治.实验性自身免疫性脑脊髓炎动物模型的比较[J].中国神经免疫学和神经病学杂志,2005,12(5):258-261. 被引量:8
  • 7Cantorna MT, Hayes CE, DeLuca HF. 1,25-Dihydroxyvitamin D3 reversibly blocks the progression of relapsing encephalomyelitis, a model of multiple sclerosis. Proc Natl Acad Sci USA, 1996, 93: 7861-7864.
  • 8Xu LY, Yang JS, Link H, et al. SIN-1, a nitric oxide donor, ameliorates experimental autoimmune encephalomyelitis in Lewis rats in the incipient phase: the importance of the time window. J Immunol, 2001, 166:5810-5816.
  • 9Garcion E, Wion- Barbot N, Montero-Menei CN, et al. New clues about vitamin D functions in the nervous system. Trends Endocrinol Metab, 2002, 13:100-105.
  • 10Muthian G, Raikwar HP, Rajasingh J, et al. 1, 25 Dihydroxyvitamin-D3 modulates JAK-STAT pathway in IL-12/ IFNgamma axis leading to Thl response in experimental allergic encephalomyelitis. J Neurosci Res, 2006, 83:1299-1309.

二级参考文献22

  • 1张凤,富羽弘.活性维生素D与多发性硬化[J].国外医学(免疫学分册),2005,28(3):159-162. 被引量:2
  • 2Stepaniack JA, Gould KE, Sun D, et al. A comparative study of experimental autoimmune encephalomyelitis in Lewis and DA rats[J]. J Immunol, 1995, 155 :2762-1769.
  • 3Johns TG, Kerlero RN, Menon KK, et al. Myelin oligodendrocyte glycoprotein induces a demyelinating encephalomyelitiss resembleing multipl sclerosis[J]. J Immunol, 1995,154:5536-5541.
  • 4Stefferl A, Brehm U, Storch M, et al. Myelin oligodendrocyte glycoprotein induces experimental autoimmune encephalomyelitis in the "resistant" Brown Norway rat: disease susceptibility is determined by MHCand MHC-linked effects on the B cell response [J]. J Immunol, 1999, 63(1) :40-49.
  • 5Lorentzen JC, Issazadeh S, Storch M, et al. Protracted, relapsing and demyelinating experimental autoimmune encephalomyelitis in DA rats immunized with syngeneic spinal cord and incomplete Freund' s adjuvant[J]. J Neuroimmunol, 1995, 63:193-205.
  • 6Reynolds R, Dawson M, Papadopoulos D, et al. The response of NG2-expressing oligodendrocyte progenitors to demyelination in MOG-EAE and MS [J]. J Neurocytol, 2002, 31: 523-536.
  • 7VanAmerongen BM, Dijkstra CD, Lips P, et al. Multiple sclerosis and vitamin D: an update. Eur J Clin Nutr, 2004, 58: 1095-1109.
  • 8Hayes CE, Cantona MT, DeLuca HF. Vitamin D and multiple sclerosis. Proc Soc Exp Biol Med, 1997, 216: 21-27.
  • 9Hayes CE. Vitamin D: a natural inhibitor of multiple sclerosis. Proc Nutr Soc, 2000, 59: 531-535.
  • 10Cantorna MT, Hayes CE, Deluca HF. 1,25-dihydroxyvitamin D3 reversibly blocks the progression of relapsing encephalomyelitis, a model of multiple sclerosis. Proc Natl Acad Sci USA,1996, 93:7861-7864.

共引文献11

同被引文献25

  • 1方湘玲,易著文,党西强,何小解,何庆南,吴小川,莫双红.儿童过敏性紫癜236例临床分析[J].临床儿科杂志,2006,24(1):46-49. 被引量:149
  • 2Petty RE, Southwood TR, Manners P, et al. International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001[J]. J Rheumatol, 2004, 31(2): 390-392.
  • 3Arnson Y, Amital H, Shoenfeld Y. Vitamin D and autoimmunity: new aetiological and therapeutic considerations[J]. Ann Rheum Dis, 2007, 66(6): 1137-1142.
  • 4Misra M, Pacaud D, Petryk A, et al. Vitamin D deficiency in children and its management: review of current knowledge and recommendations[J]. Pediatrics, 2008, 122(2): 398-417.
  • 5Nisar MK, Masood F, Cookson P, et al. What do we know about juvenile idiopathic arthritis and vitamin D? A systematic literature review and meta-analysis of current evidence[J]. Clin Rheumatol, 2013, 32(6): 729-734.
  • 6Szymanska KJ, Biernacka ZM, Stanczyk J. Vitamin D level in children with juvenile idiopathic arthritis and its correlation with clinical picture of the disease[J]. Reumatologia, 2013, 51(4): 271-276.
  • 7Pel a jo CF, Lopez-Beni t e z JM, Ken t DM, et a l . 25-Hydroxyvitamin D levels and juvenile idiopathic arthritis: Is there an association with disease activity?[J]. Rheumatol Int, 2012, 32(12): 3923-3929.
  • 8Dawson-Hughes B, Heaney RP, Holick MF, et al. Estimates of optimal vitamin D status[J]. Osteoporos Int, 2005, 16(7): 713- 716.
  • 9Holick MF. Resurrection of vitamin D deficiency and rickets[J]. J Clin Invest, 2006, 116(8): 2062-2072.
  • 10Holick MF. Vitamin D deficiency[J]. N Engl, 2007, 357(3): 266- 281.

引证文献2

二级引证文献34

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部